Ruthie Davi, vice president of statistics and regulatory innovation at Medidata, highlights the value of technology in rare ...

ClinCapture President and CEO Scott Weidley today announced a major expansion of artificial intelligence capabilities within the company's Captivate® platform, embedding AI directly into the ...

The global healthcare predictive analytics market is experiencing growth due to several factors such as convergence of data availability, technological advancements, regulatory imperatives, and ...

The Transplant Company™, a leading precision medicine company focused on the discovery, development, and commercialization of clinically differentiated, high‑value healthcare solutions for transplant ...

Enhanced AI adoption for predictive drug safety analytics, laboratory process automation, and cost-efficient research pipelines are fueling growth. Expansion in biological datasets, cloud ...

The AI in Life Science Market is anticipated to experience a remarkable compound annual growth rate (CAGR) of around 25% in the coming years, highlighting the increasing reliance on AI technologies ...

OmniMD introduces a unified AI-powered clinical–financial platform delivering predictive revenue insights, automation, ...

Discover how pre-stratification enables you to reduce clinical trial size without sacrificing statistical power.

As clinical development grows more complex, sponsors are rethinking how outsourcing models, technology, and partnerships align to support both speed and sustainability. The shift toward hybrid models, ...

Overview Artificial intelligence seems to be transforming drug discovery in 2026, enabling faster molecule design, smarter clinical trials, and reduced R&D ...

Predictive analytics boost AI tools and help patients and clinicians connect. However, HIMSS Chief Scientific Research Officer Anne Snowdon says that, globally, only about 30% of ...